nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—UGT1A6—Mycophenolic acid—systemic scleroderma	0.563	0.642	CbGbCtD
Deferiprone—UGT1A6—Mycophenolate mofetil—systemic scleroderma	0.315	0.358	CbGbCtD
Deferiprone—Discomfort—Leflunomide—systemic scleroderma	0.000214	0.00175	CcSEcCtD
Deferiprone—Skin disorder—Azathioprine—systemic scleroderma	0.000213	0.00174	CcSEcCtD
Deferiprone—Back pain—Lisinopril—systemic scleroderma	0.000211	0.00173	CcSEcCtD
Deferiprone—Vomiting—Pentoxifylline—systemic scleroderma	0.000211	0.00173	CcSEcCtD
Deferiprone—Convulsion—Mycophenolic acid—systemic scleroderma	0.00021	0.00172	CcSEcCtD
Deferiprone—Rash—Pentoxifylline—systemic scleroderma	0.000209	0.00171	CcSEcCtD
Deferiprone—Hypertension—Mycophenolic acid—systemic scleroderma	0.000209	0.00171	CcSEcCtD
Deferiprone—Dermatitis—Pentoxifylline—systemic scleroderma	0.000209	0.00171	CcSEcCtD
Deferiprone—Headache—Pentoxifylline—systemic scleroderma	0.000208	0.0017	CcSEcCtD
Deferiprone—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000207	0.0017	CcSEcCtD
Deferiprone—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000206	0.00169	CcSEcCtD
Deferiprone—Infection—Leflunomide—systemic scleroderma	0.000206	0.00168	CcSEcCtD
Deferiprone—Gastrointestinal pain—Captopril—systemic scleroderma	0.000206	0.00168	CcSEcCtD
Deferiprone—Asthenia—Mometasone—systemic scleroderma	0.000205	0.00168	CcSEcCtD
Deferiprone—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000205	0.00168	CcSEcCtD
Deferiprone—Hypotension—Azathioprine—systemic scleroderma	0.000205	0.00168	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000205	0.00168	CcSEcCtD
Deferiprone—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00167	CcSEcCtD
Deferiprone—Discomfort—Mycophenolic acid—systemic scleroderma	0.000204	0.00167	CcSEcCtD
Deferiprone—Nervous system disorder—Leflunomide—systemic scleroderma	0.000203	0.00166	CcSEcCtD
Deferiprone—Pruritus—Mometasone—systemic scleroderma	0.000203	0.00166	CcSEcCtD
Deferiprone—Skin disorder—Leflunomide—systemic scleroderma	0.000201	0.00165	CcSEcCtD
Deferiprone—Hyperhidrosis—Leflunomide—systemic scleroderma	0.0002	0.00164	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.0002	0.00164	CcSEcCtD
Deferiprone—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00163	CcSEcCtD
Deferiprone—Body temperature increased—Captopril—systemic scleroderma	0.000199	0.00163	CcSEcCtD
Deferiprone—Abdominal pain—Captopril—systemic scleroderma	0.000199	0.00163	CcSEcCtD
Deferiprone—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00162	CcSEcCtD
Deferiprone—Nausea—Pentoxifylline—systemic scleroderma	0.000197	0.00161	CcSEcCtD
Deferiprone—Chills—Mycophenolate mofetil—systemic scleroderma	0.000197	0.00161	CcSEcCtD
Deferiprone—Infection—Mycophenolic acid—systemic scleroderma	0.000196	0.00161	CcSEcCtD
Deferiprone—Diarrhoea—Mometasone—systemic scleroderma	0.000196	0.0016	CcSEcCtD
Deferiprone—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000194	0.00159	CcSEcCtD
Deferiprone—Hypotension—Leflunomide—systemic scleroderma	0.000194	0.00158	CcSEcCtD
Deferiprone—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00157	CcSEcCtD
Deferiprone—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000192	0.00157	CcSEcCtD
Deferiprone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00156	CcSEcCtD
Deferiprone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000191	0.00156	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00019	0.00155	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000189	0.00155	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000189	0.00154	CcSEcCtD
Deferiprone—Arthralgia—Lisinopril—systemic scleroderma	0.000186	0.00152	CcSEcCtD
Deferiprone—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00151	CcSEcCtD
Deferiprone—Hypotension—Mycophenolic acid—systemic scleroderma	0.000185	0.00151	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000185	0.00151	CcSEcCtD
Deferiprone—Discomfort—Lisinopril—systemic scleroderma	0.000184	0.0015	CcSEcCtD
Deferiprone—Dyspepsia—Leflunomide—systemic scleroderma	0.000182	0.00149	CcSEcCtD
Deferiprone—Pancreatitis—Prednisone—systemic scleroderma	0.000182	0.00149	CcSEcCtD
Deferiprone—Vomiting—Mometasone—systemic scleroderma	0.000182	0.00149	CcSEcCtD
Deferiprone—Rash—Mometasone—systemic scleroderma	0.000181	0.00148	CcSEcCtD
Deferiprone—Asthenia—Captopril—systemic scleroderma	0.00018	0.00148	CcSEcCtD
Deferiprone—Dermatitis—Mometasone—systemic scleroderma	0.00018	0.00148	CcSEcCtD
Deferiprone—Decreased appetite—Leflunomide—systemic scleroderma	0.00018	0.00147	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00018	0.00147	CcSEcCtD
Deferiprone—Osteoarthritis—Methotrexate—systemic scleroderma	0.00018	0.00147	CcSEcCtD
Deferiprone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000179	0.00147	CcSEcCtD
Deferiprone—Headache—Mometasone—systemic scleroderma	0.000179	0.00147	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000179	0.00146	CcSEcCtD
Deferiprone—Fatigue—Leflunomide—systemic scleroderma	0.000179	0.00146	CcSEcCtD
Deferiprone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000178	0.00146	CcSEcCtD
Deferiprone—Pruritus—Captopril—systemic scleroderma	0.000178	0.00146	CcSEcCtD
Deferiprone—Pain—Leflunomide—systemic scleroderma	0.000177	0.00145	CcSEcCtD
Deferiprone—Infection—Lisinopril—systemic scleroderma	0.000177	0.00145	CcSEcCtD
Deferiprone—Somnolence—Mycophenolic acid—systemic scleroderma	0.000176	0.00144	CcSEcCtD
Deferiprone—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000174	0.00142	CcSEcCtD
Deferiprone—Neutropenia—Prednisone—systemic scleroderma	0.000174	0.00142	CcSEcCtD
Deferiprone—Abdominal pain—Azathioprine—systemic scleroderma	0.000174	0.00142	CcSEcCtD
Deferiprone—Body temperature increased—Azathioprine—systemic scleroderma	0.000174	0.00142	CcSEcCtD
Deferiprone—Skin disorder—Lisinopril—systemic scleroderma	0.000173	0.00142	CcSEcCtD
Deferiprone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000172	0.00141	CcSEcCtD
Deferiprone—Diarrhoea—Captopril—systemic scleroderma	0.000172	0.00141	CcSEcCtD
Deferiprone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000172	0.00141	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000171	0.0014	CcSEcCtD
Deferiprone—Fatigue—Mycophenolic acid—systemic scleroderma	0.00017	0.00139	CcSEcCtD
Deferiprone—Nausea—Mometasone—systemic scleroderma	0.00017	0.00139	CcSEcCtD
Deferiprone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000169	0.00139	CcSEcCtD
Deferiprone—Weight increased—Prednisone—systemic scleroderma	0.000169	0.00138	CcSEcCtD
Deferiprone—Pain—Mycophenolic acid—systemic scleroderma	0.000169	0.00138	CcSEcCtD
Deferiprone—Hypotension—Lisinopril—systemic scleroderma	0.000166	0.00136	CcSEcCtD
Deferiprone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00136	CcSEcCtD
Deferiprone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00135	CcSEcCtD
Deferiprone—Urticaria—Leflunomide—systemic scleroderma	0.000165	0.00135	CcSEcCtD
Deferiprone—Abdominal pain—Leflunomide—systemic scleroderma	0.000164	0.00134	CcSEcCtD
Deferiprone—Body temperature increased—Leflunomide—systemic scleroderma	0.000164	0.00134	CcSEcCtD
Deferiprone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00133	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000162	0.00133	CcSEcCtD
Deferiprone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000162	0.00132	CcSEcCtD
Deferiprone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000162	0.00132	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000162	0.00132	CcSEcCtD
Deferiprone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000161	0.00132	CcSEcCtD
Deferiprone—Vomiting—Captopril—systemic scleroderma	0.00016	0.00131	CcSEcCtD
Deferiprone—Rash—Captopril—systemic scleroderma	0.000159	0.0013	CcSEcCtD
Deferiprone—Dermatitis—Captopril—systemic scleroderma	0.000158	0.0013	CcSEcCtD
Deferiprone—Somnolence—Lisinopril—systemic scleroderma	0.000158	0.0013	CcSEcCtD
Deferiprone—Headache—Captopril—systemic scleroderma	0.000158	0.00129	CcSEcCtD
Deferiprone—Dyspepsia—Lisinopril—systemic scleroderma	0.000157	0.00128	CcSEcCtD
Deferiprone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000156	0.00128	CcSEcCtD
Deferiprone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000156	0.00128	CcSEcCtD
Deferiprone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00128	CcSEcCtD
Deferiprone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00127	CcSEcCtD
Deferiprone—Decreased appetite—Lisinopril—systemic scleroderma	0.000155	0.00127	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000154	0.00126	CcSEcCtD
Deferiprone—Fatigue—Lisinopril—systemic scleroderma	0.000154	0.00126	CcSEcCtD
Deferiprone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000153	0.00125	CcSEcCtD
Deferiprone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000153	0.00125	CcSEcCtD
Deferiprone—Pancreatitis—Methotrexate—systemic scleroderma	0.000152	0.00125	CcSEcCtD
Deferiprone—Pain—Lisinopril—systemic scleroderma	0.000152	0.00125	CcSEcCtD
Deferiprone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00124	CcSEcCtD
Deferiprone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00123	CcSEcCtD
Deferiprone—Diarrhoea—Azathioprine—systemic scleroderma	0.00015	0.00123	CcSEcCtD
Deferiprone—Nausea—Captopril—systemic scleroderma	0.000149	0.00122	CcSEcCtD
Deferiprone—Asthenia—Leflunomide—systemic scleroderma	0.000149	0.00122	CcSEcCtD
Deferiprone—Pancytopenia—Methotrexate—systemic scleroderma	0.000148	0.00121	CcSEcCtD
Deferiprone—Pruritus—Leflunomide—systemic scleroderma	0.000147	0.0012	CcSEcCtD
Deferiprone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000146	0.0012	CcSEcCtD
Deferiprone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00119	CcSEcCtD
Deferiprone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000146	0.00119	CcSEcCtD
Deferiprone—Neutropenia—Methotrexate—systemic scleroderma	0.000145	0.00119	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000142	0.00116	CcSEcCtD
Deferiprone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000142	0.00116	CcSEcCtD
Deferiprone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000142	0.00116	CcSEcCtD
Deferiprone—Diarrhoea—Leflunomide—systemic scleroderma	0.000142	0.00116	CcSEcCtD
Deferiprone—Urticaria—Lisinopril—systemic scleroderma	0.000141	0.00116	CcSEcCtD
Deferiprone—Abdominal pain—Lisinopril—systemic scleroderma	0.000141	0.00115	CcSEcCtD
Deferiprone—Body temperature increased—Lisinopril—systemic scleroderma	0.000141	0.00115	CcSEcCtD
Deferiprone—Pruritus—Mycophenolic acid—systemic scleroderma	0.00014	0.00114	CcSEcCtD
Deferiprone—Vomiting—Azathioprine—systemic scleroderma	0.00014	0.00114	CcSEcCtD
Deferiprone—Pneumonia—Methotrexate—systemic scleroderma	0.000139	0.00114	CcSEcCtD
Deferiprone—Eye disorder—Prednisone—systemic scleroderma	0.000139	0.00114	CcSEcCtD
Deferiprone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000139	0.00113	CcSEcCtD
Deferiprone—Infestation NOS—Methotrexate—systemic scleroderma	0.000139	0.00113	CcSEcCtD
Deferiprone—Infestation—Methotrexate—systemic scleroderma	0.000139	0.00113	CcSEcCtD
Deferiprone—Rash—Azathioprine—systemic scleroderma	0.000138	0.00113	CcSEcCtD
Deferiprone—Dermatitis—Azathioprine—systemic scleroderma	0.000138	0.00113	CcSEcCtD
Deferiprone—Headache—Azathioprine—systemic scleroderma	0.000137	0.00112	CcSEcCtD
Deferiprone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00112	CcSEcCtD
Deferiprone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000136	0.00111	CcSEcCtD
Deferiprone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000135	0.00111	CcSEcCtD
Deferiprone—Angiopathy—Prednisone—systemic scleroderma	0.000135	0.00111	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000135	0.0011	CcSEcCtD
Deferiprone—Immune system disorder—Prednisone—systemic scleroderma	0.000134	0.0011	CcSEcCtD
Deferiprone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00109	CcSEcCtD
Deferiprone—Vomiting—Leflunomide—systemic scleroderma	0.000132	0.00108	CcSEcCtD
Deferiprone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000131	0.00107	CcSEcCtD
Deferiprone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000131	0.00107	CcSEcCtD
Deferiprone—Epistaxis—Methotrexate—systemic scleroderma	0.000131	0.00107	CcSEcCtD
Deferiprone—Rash—Leflunomide—systemic scleroderma	0.000131	0.00107	CcSEcCtD
Deferiprone—Dermatitis—Leflunomide—systemic scleroderma	0.000131	0.00107	CcSEcCtD
Deferiprone—Mental disorder—Prednisone—systemic scleroderma	0.00013	0.00107	CcSEcCtD
Deferiprone—Nausea—Azathioprine—systemic scleroderma	0.00013	0.00107	CcSEcCtD
Deferiprone—Headache—Leflunomide—systemic scleroderma	0.00013	0.00106	CcSEcCtD
Deferiprone—Malnutrition—Prednisone—systemic scleroderma	0.00013	0.00106	CcSEcCtD
Deferiprone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000129	0.00106	CcSEcCtD
Deferiprone—Asthenia—Lisinopril—systemic scleroderma	0.000128	0.00105	CcSEcCtD
Deferiprone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000128	0.00104	CcSEcCtD
Deferiprone—Pruritus—Lisinopril—systemic scleroderma	0.000126	0.00103	CcSEcCtD
Deferiprone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000126	0.00103	CcSEcCtD
Deferiprone—Rash—Mycophenolic acid—systemic scleroderma	0.000125	0.00102	CcSEcCtD
Deferiprone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000125	0.00102	CcSEcCtD
Deferiprone—Hepatitis—Methotrexate—systemic scleroderma	0.000124	0.00102	CcSEcCtD
Deferiprone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000124	0.00101	CcSEcCtD
Deferiprone—Headache—Mycophenolic acid—systemic scleroderma	0.000124	0.00101	CcSEcCtD
Deferiprone—Pharyngitis—Methotrexate—systemic scleroderma	0.000123	0.00101	CcSEcCtD
Deferiprone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00101	CcSEcCtD
Deferiprone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00101	CcSEcCtD
Deferiprone—Nausea—Leflunomide—systemic scleroderma	0.000123	0.00101	CcSEcCtD
Deferiprone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000123	0.00101	CcSEcCtD
Deferiprone—Urethral disorder—Methotrexate—systemic scleroderma	0.000122	0.000998	CcSEcCtD
Deferiprone—Diarrhoea—Lisinopril—systemic scleroderma	0.000122	0.000997	CcSEcCtD
Deferiprone—Nausea—Mycophenolic acid—systemic scleroderma	0.000117	0.000961	CcSEcCtD
Deferiprone—Eye disorder—Methotrexate—systemic scleroderma	0.000116	0.000951	CcSEcCtD
Deferiprone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000115	0.000945	CcSEcCtD
Deferiprone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000941	CcSEcCtD
Deferiprone—Vomiting—Lisinopril—systemic scleroderma	0.000113	0.000926	CcSEcCtD
Deferiprone—Angiopathy—Methotrexate—systemic scleroderma	0.000113	0.000924	CcSEcCtD
Deferiprone—Immune system disorder—Methotrexate—systemic scleroderma	0.000112	0.000919	CcSEcCtD
Deferiprone—Rash—Lisinopril—systemic scleroderma	0.000112	0.000919	CcSEcCtD
Deferiprone—Convulsion—Prednisone—systemic scleroderma	0.000112	0.000919	CcSEcCtD
Deferiprone—Dermatitis—Lisinopril—systemic scleroderma	0.000112	0.000918	CcSEcCtD
Deferiprone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000112	0.000917	CcSEcCtD
Deferiprone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000916	CcSEcCtD
Deferiprone—Hypertension—Prednisone—systemic scleroderma	0.000112	0.000915	CcSEcCtD
Deferiprone—Chills—Methotrexate—systemic scleroderma	0.000112	0.000913	CcSEcCtD
Deferiprone—Headache—Lisinopril—systemic scleroderma	0.000112	0.000913	CcSEcCtD
Deferiprone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000903	CcSEcCtD
Deferiprone—Arthralgia—Prednisone—systemic scleroderma	0.00011	0.000903	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00011	0.000896	CcSEcCtD
Deferiprone—Discomfort—Prednisone—systemic scleroderma	0.000109	0.000892	CcSEcCtD
Deferiprone—Mental disorder—Methotrexate—systemic scleroderma	0.000109	0.000892	CcSEcCtD
Deferiprone—Malnutrition—Methotrexate—systemic scleroderma	0.000108	0.000886	CcSEcCtD
Deferiprone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000873	CcSEcCtD
Deferiprone—Nausea—Lisinopril—systemic scleroderma	0.000106	0.000865	CcSEcCtD
Deferiprone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000106	0.000865	CcSEcCtD
Deferiprone—Infection—Prednisone—systemic scleroderma	0.000105	0.00086	CcSEcCtD
Deferiprone—Back pain—Methotrexate—systemic scleroderma	0.000105	0.000857	CcSEcCtD
Deferiprone—Nervous system disorder—Prednisone—systemic scleroderma	0.000104	0.000849	CcSEcCtD
Deferiprone—Skin disorder—Prednisone—systemic scleroderma	0.000103	0.00084	CcSEcCtD
Deferiprone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000102	0.000837	CcSEcCtD
Deferiprone—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.92e-05	0.000812	CcSEcCtD
Deferiprone—Rash—Mycophenolate mofetil—systemic scleroderma	9.84e-05	0.000805	CcSEcCtD
Deferiprone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.83e-05	0.000804	CcSEcCtD
Deferiprone—Headache—Mycophenolate mofetil—systemic scleroderma	9.78e-05	0.0008	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.64e-05	0.000788	CcSEcCtD
Deferiprone—Convulsion—Methotrexate—systemic scleroderma	9.38e-05	0.000768	CcSEcCtD
Deferiprone—Dyspepsia—Prednisone—systemic scleroderma	9.31e-05	0.000762	CcSEcCtD
Deferiprone—Nausea—Mycophenolate mofetil—systemic scleroderma	9.27e-05	0.000758	CcSEcCtD
Deferiprone—Arthralgia—Methotrexate—systemic scleroderma	9.22e-05	0.000754	CcSEcCtD
Deferiprone—Decreased appetite—Prednisone—systemic scleroderma	9.2e-05	0.000752	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.16e-05	0.000749	CcSEcCtD
Deferiprone—Fatigue—Prednisone—systemic scleroderma	9.12e-05	0.000746	CcSEcCtD
Deferiprone—Discomfort—Methotrexate—systemic scleroderma	9.11e-05	0.000745	CcSEcCtD
Deferiprone—Anaphylactic shock—Methotrexate—systemic scleroderma	8.84e-05	0.000723	CcSEcCtD
Deferiprone—Infection—Methotrexate—systemic scleroderma	8.78e-05	0.000718	CcSEcCtD
Deferiprone—Nervous system disorder—Methotrexate—systemic scleroderma	8.67e-05	0.000709	CcSEcCtD
Deferiprone—Gastrointestinal pain—Prednisone—systemic scleroderma	8.65e-05	0.000708	CcSEcCtD
Deferiprone—Skin disorder—Methotrexate—systemic scleroderma	8.59e-05	0.000702	CcSEcCtD
Deferiprone—Hyperhidrosis—Methotrexate—systemic scleroderma	8.55e-05	0.000699	CcSEcCtD
Deferiprone—Urticaria—Prednisone—systemic scleroderma	8.4e-05	0.000687	CcSEcCtD
Deferiprone—Body temperature increased—Prednisone—systemic scleroderma	8.36e-05	0.000684	CcSEcCtD
Deferiprone—Abdominal pain—Prednisone—systemic scleroderma	8.36e-05	0.000684	CcSEcCtD
Deferiprone—Hypotension—Methotrexate—systemic scleroderma	8.26e-05	0.000676	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.05e-05	0.000659	CcSEcCtD
Deferiprone—Somnolence—Methotrexate—systemic scleroderma	7.86e-05	0.000643	CcSEcCtD
Deferiprone—Hypersensitivity—Prednisone—systemic scleroderma	7.79e-05	0.000638	CcSEcCtD
Deferiprone—Dyspepsia—Methotrexate—systemic scleroderma	7.78e-05	0.000637	CcSEcCtD
Deferiprone—Decreased appetite—Methotrexate—systemic scleroderma	7.68e-05	0.000629	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.63e-05	0.000624	CcSEcCtD
Deferiprone—Fatigue—Methotrexate—systemic scleroderma	7.62e-05	0.000623	CcSEcCtD
Deferiprone—Asthenia—Prednisone—systemic scleroderma	7.59e-05	0.000621	CcSEcCtD
Deferiprone—Pain—Methotrexate—systemic scleroderma	7.56e-05	0.000618	CcSEcCtD
Deferiprone—Pruritus—Prednisone—systemic scleroderma	7.48e-05	0.000612	CcSEcCtD
Deferiprone—Diarrhoea—Prednisone—systemic scleroderma	7.24e-05	0.000592	CcSEcCtD
Deferiprone—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.23e-05	0.000591	CcSEcCtD
Deferiprone—Urticaria—Methotrexate—systemic scleroderma	7.02e-05	0.000574	CcSEcCtD
Deferiprone—Body temperature increased—Methotrexate—systemic scleroderma	6.99e-05	0.000572	CcSEcCtD
Deferiprone—Abdominal pain—Methotrexate—systemic scleroderma	6.99e-05	0.000572	CcSEcCtD
Deferiprone—Vomiting—Prednisone—systemic scleroderma	6.73e-05	0.00055	CcSEcCtD
Deferiprone—Rash—Prednisone—systemic scleroderma	6.67e-05	0.000546	CcSEcCtD
Deferiprone—Dermatitis—Prednisone—systemic scleroderma	6.66e-05	0.000545	CcSEcCtD
Deferiprone—Headache—Prednisone—systemic scleroderma	6.63e-05	0.000542	CcSEcCtD
Deferiprone—Hypersensitivity—Methotrexate—systemic scleroderma	6.51e-05	0.000533	CcSEcCtD
Deferiprone—Asthenia—Methotrexate—systemic scleroderma	6.34e-05	0.000519	CcSEcCtD
Deferiprone—Nausea—Prednisone—systemic scleroderma	6.28e-05	0.000514	CcSEcCtD
Deferiprone—Pruritus—Methotrexate—systemic scleroderma	6.25e-05	0.000512	CcSEcCtD
Deferiprone—Diarrhoea—Methotrexate—systemic scleroderma	6.05e-05	0.000495	CcSEcCtD
Deferiprone—Vomiting—Methotrexate—systemic scleroderma	5.62e-05	0.00046	CcSEcCtD
Deferiprone—Rash—Methotrexate—systemic scleroderma	5.57e-05	0.000456	CcSEcCtD
Deferiprone—Dermatitis—Methotrexate—systemic scleroderma	5.57e-05	0.000456	CcSEcCtD
Deferiprone—Headache—Methotrexate—systemic scleroderma	5.54e-05	0.000453	CcSEcCtD
Deferiprone—Nausea—Methotrexate—systemic scleroderma	5.25e-05	0.00043	CcSEcCtD
